top of page

Developing transformative cancer medicines with CD19-Redirected ARTEMIS T Cells to improve patients’ lives

Frame 123.png

Estrella Innovations

Recent scientific breakthroughs in cell therapy have revealed potentials for patient care beyond hematological malignancies. Standing at the edge of the new frontier of malignant cancer treatments, we at Estrella are committed to translating scientific innovations into next-generation T-cell therapies that can address treatment challenges in both hematological malignancies and solid tumors.

Management

Copy of IMG_8849-01.jpg

Cheng Liu, PhD

President and CEO

photo_2022-07-03_23-01-09.jpg

Jiandong (Peter) Xu

Chief Financial Officer

Scientific Advisory Board

3.jpg

David A. Scheinberg, MD, PhD

Memorial Sloan Kettering Cancer Center

6.png

W. Michael Kavanaugh, MD

University of California, San Francisco

4.jpg

Stephan A. Grupp, MD, PhD

Children’s Hospital of Philadelphia (CHOP)

gianpietro-dotti-scaled (1)_edited.jpg

Gianpietro Dotti,

MD

University of North Carolina

5 1.png

Randy W. Schekman, PhD

University of California, Berkeley

Рисунок1.jpg

Careers

We are an energetic, science-driven team. We passionately pursue innovations that will help improve the lives of cancer patients. Our goal is to unlock the full potential of T-cell therapies and expand its curative power in both hematological malignancies and solid tumors. As we continue to grow, we are looking for curious, collaborative and entrepreneurial talents to join our team.

 

If you would like to be considered for a position at Estrella, please submit your resume and cover letter to careers@estrellabio.com.

bottom of page